Evidence map›Paper›PMID 40301947›Full record

ArticleEuropean journal of medical research2025

NF-κB-mediated enhancement of H3K27me3 through EZH2: a mechanism to suppress pyocyanin-induced autophagy in macrophages.

Ji Wang, Min Bian, Simin Liang, Xiaowei Yi, Yu Du

Abstract read
In one paragraph

Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ji Wang *Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.ORCID http://orcid.org/0000-0001-5871-3626
Min Bian *Department of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.ORCID http://orcid.org/0009-0006-2833-6587
Simin Liang *Department of Anesthesiology, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital/the Second Clinical Medical Institution, North Sichuan Medical College, Nanchong, 637000, China.ORCID http://orcid.org/0009-0009-8416-6633
Xiaowei YiDepartment of Anesthesiology, Affiliated Hospital of North Sichuan Medical College, Nanchong, China.ORCID http://orcid.org/0009-0003-5604-2920
Yu DuDepartment of Anesthesiology, Beijing Anzhen Nanchong Hospital, Capital Medical University & Nanchong Central Hospital/the Second Clinical Medical Institution, North Sichuan Medical College, Nanchong, 637000, China. 542861618@qq.com.ORCID http://orcid.org/0009-0004-1124-0832

Funding

National Natural Science Foundation of China 82201353the School-Level Scientific Research Development Plan Project of North Sichuan Medical College CBY21-QD20the School-Level Scientific Research Development Plan Project of North Sichuan Medical College CBY23-QNA12the Science and Technology Bureau of Nanchong City, Sichuan Province, China 22SXZRKX0008
6 · The paper itself

Abstract

backgroundHistone modification is a key mechanism of epigenetic regulation. Our previous study demonstrated that histone H3 acetylation at lysine 27 (H3K27ac) promotes pyocyanin (PYO)-induced autophagy in macrophages. However, the regulatory role of H3K27 trimethylation (H3K27me3) in this process remains unclear.

methodsTHP-1 macrophages were treated with PYO, and autophagy was assessed by evaluating LC3B II expression and autophagosome formation. The expression of EZH2 and JMJD3 was analyzed to identify the key enzyme responsible for regulating H3K27me3. Nuclear-cytoplasmic fractionation and co-immunoprecipitation were performed to determine the distribution of NF-κB and its interaction with H3K27me3. To explore the role of H3K27me3 in PYO-induced autophagy, cells were co-treated with PYO and EZH2 inhibitors (EI1 or CPI-169), and the transcription of ULK1, BECN1, and MAP1LC3B was analyzed using ChIP-qPCR. Similarly, to assess the role of NF-κB, cells were co-treated with PYO and the NF-κB nuclear translocation inhibitor curcumin, followed by ChIP-qPCR analysis. Finally, the reciprocal transcriptional regulation between NF-κB and H3K27me3 was further investigated.

resultsPYO increases LC3B II expression and autophagosome formation in THP-1 macrophages. It also elevates H3K27me3 levels by upregulating EZH2 expression, while JMJD3 remains unchanged. Co-treatment with EZH2 inhibitors reduces H3K27me3 levels, leading to increased LC3B II expression and enhanced autophagosome formation. ChIP-qPCR analysis shows that H3K27me3 enrichment at the ULK1 and MAP1LC3B promoters correlates with reduced transcription, whereas BECN1 remains unaffected. PYO promotes nuclear translocation of NF-κB and enhances its interaction with H3K27me3. ChIP-qPCR further reveals that NF-κB represses the transcription of ULK1 and MAP1LC3B and upregulates EZH2 transcription, which contributes to increased H3K27me3 levels and further suppression of autophagy-related gene expression.

conclusionsThe NF-κB/EZH2/H3K27me3 axis plays a pivotal role in suppressing PYO-induced autophagy in macrophages by repressing the transcription of ULK1 and MAP1LC3B.

Indexed as

AutophagyEnhancer of Zeste Homolog 2 ProteinHistonesMacrophagesNF-kappa BAutophagy-Related Protein-1 HomologHumansIntracellular Signaling Peptides and ProteinsJumonji Domain-Containing Histone DemethylasesMethylationMicrotubule-Associated ProteinsTHP-1 CellsAutophagy-Related Protein-1 HomologEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanHistonesIntracellular Signaling Peptides and ProteinsJumonji Domain-Containing Histone DemethylasesKDM6B protein, humanMAP1LC3B protein, humanMicrotubule-Associated ProteinsNF-kappa BULK1 protein, humanAutophagyEZH2H3K27me3MacrophagesNF-κBPyocyanin

Identifiers

PMID40301947
PMCPMC12038963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.